A Non-Interventional, Open Label, Phase IV Observational Study for the Safety and Efficacy of Switching to Quetiapine (Seroquel) in Outpatients With Schizophrenia Who Have Been Unsuccessfully Treated With Other Antipsychotics
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2010
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Acronyms Q-chase
- Sponsors AstraZeneca
- 08 Dec 2010 Last checked against clinicaltrials.gov record.
- 25 Jun 2008 New trial record.